Exosomes are nano-sized vesicles ranging from 30-200nm that are present in eukaryotic fluids and facilitate a diverse range of cellular functions. They transfer DNA, RNA, and proteins to other cells, thereby altering the function of the targeted cells.

Because of their far ranging potential, exosomes can be commercialized as therapeutic agents, diagnostic tools, and cosmeceuticals. Today, a surging number of companies are developing exosome-based products and technologies.

Exosome Market Competitors

Currently, there are at least 45 market competitors which compose the exosome industry in the therapeutics and diagnostics. Twenty six of them are born to be exosome companies and nineteen of them are established companies recently jumped into the exosome industry.

In the market analysis below, we present graphs and figures that elucidate key trends from across the exosome landscape. Particular emphasis is given to rates of exosomes papers and granted patents, as well as the rate at which competitors have entered the marketplace and their geographic distribution.

Summary of Findings and Future Projections

Substantial growth is expected for the exosomes market as these nano-vesicles gain momentum within existing applications and continue to get leveraged within emerging fields, such as liquid biopsy, precision medicine and regenerative medicine. Globally, new market competitors are unlikely to surface in the near-term due to the global COVID-19 pandemic, but we anticipate that new market competition will emerge as the pandemic resolves.

url : https://bioinformant.com/exosome-therapeutics-diagnostics/